The Start-up Slams are sponsored by:

Discover below the start-ups which will pitch during BioFIT 2018:

  • THERAPEUTICS – CANCER | IMMUNO-ONCOLOGY
  • DELIVERY | RESEARCH TOOLS
  • PRODUCTION TOOLS
  • DIAGNOSTICS
  • THERAPEUTICS – OTHER INDICATIONS

Start-up Slams Agenda

Tuesday, December 4th | 2.30 – 4.00 pm

THERAPEUTICS – CANCER | IMMUNO-ONCOLOGY

Elasmogen Ltd (UK)

  • SoloMERs
  • Biologics
  • Site-specific

 

OncoQR ML GmbH (AT)

  • Unique novel vaccine for immuno-oncology – target-specific and highly controllable
  • Simultaneous activation of the B-cell and T-cell path without inducing auto-immune disease or triggering side-effects
  • Incredible IgG titres with very low amount of vaccine

 

Peptomyc S.L. (ES)

  • Cancer therapy
  • Peptide therapeutics
  • Anti-Myc therapy

 

 Odimma (FR)

  • Personalised Medicine
  • Cancer Immunotherapy
  • Neoantigens

 

 OPSYON (DE)

  • Fusion tumor targeting and immune checkpoint blockade
  • Bifunctional antibody fusion protein to reduced side effects
  • Next‐generation immune checkpoint inhibitor

 

LIfT BioSciences (UK)

  • First-in-class neutrophil based allogeneic innate cell therapy (ATMP) for solid tumours
  • Clinical trial evidence of safety and 80% tumour necrosis
  • Destroys all solid tumours, irrespective of mutation or strain

 

 Tubulis (DE)

  • Superior Antibody Drug Conjugates (ADCs) for targeted cancer therapy
  • Next-gen ADC conjugation
  • Catalyzing successful ADC development and overcoming existing obstacles

Wednesday, December 5th | 9.00 – 10.30 am

DELIVERY | RESEARCH TOOLS

MyLife Technologies (NL)

  • Nanoporous microneedle technology
  • Dermal drug delivery
  • Peptides, small molecules, vaccines

 

ATLANGRAM (FR)

  • Antibiotic
  • Resistance
  • Drug delivery

 

Mind the Byte (ES)

  • Drug Discovery
  • Artificial Intelligence
  • Cloud Computing

 

InBrain Pharma (FR)

  • Brain Infusion
  • Neurodegenerative diseases
  • Parkinson’s disease

 

 GTN LTD (UK)

  • Biotech
  • Machine Learning
  • Drug Discovery

PRODUCTION TOOLS

NUMAFERM (DE)

  • Biomade Peptides
  • Efficient and Reliable Bioproduction of Peptides
  • Short ramp-up

 

 UGISense AG (DE)

  • Ugimer™ antisense-technology
  • Proprietary platform technology
  • Drug development in collaboration with industrial partners

Wednesday, December 5th | 2.00 – 3.30 pm

DIAGNOSTICS

Carmentix (SG)

  • Diagnostics
  • Preterm Birth
  • Data Mining

 

Sencet (FR)

  • Cancer diagnostics
  • Characterization of circulating tumor cells
  • Single Cell analysis

THERAPEUTICS – OTHER INDICATIONS

Phyteau (US)

  • Diabetes, obesity and metabolism
  • Enteroendocrine cell receptor agonists
  • Completely safe, side-effect-free

 

APIOS (FR)

  • Bone reconstruction
  • Orthobiologics
  • Drug delivery

 

Madam Therapeutics (NL)

  • Anti-infectives
  • Anti-microbial resistance
  • Antibiotics

 

MTact (FR)

  • Alzheimer disease
  • Microtubules targeting agents
  • First-in-class

 

Op2Lysis (FR)

  • Intracerebral Hemorrhage (ICH) or hemorrhagic stroke
  • Biotechnology
  • MoA = safe and effective evacuation of brain hematoma

AWARD CEREMONY
December 5th at 3.30 pm

The most innovative start-ups will be awarded on BioFIT 2nd day at 3.30 pm in the exhibition hall.